EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decoding amyloid beta clearance systems at inner blood–retina barrier using three‐dimensional ex vivo retinal imaging in Alzheimer's disease

Printha Wijesinghe, Amir Hosseini, Matthew Campbell, Shivani Tejpal, Justin Haynes, Jeanne Xi, Ian R Mackenzie, Veronica Hirsch-Reinshagen, Ging-Yuek Robin Hsiung, Benjamin W Spiller, Brian E Wadzinski, Wellington Pham und 1 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Printha Wijesinghe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Visual Sciences, Faculty of Medicine, The University of British Columbia, Eye Care Centre, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Blood-Retinal Barrier, Retina. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alzheimer Society of Canada and Brain Canada, National Sciences and Engineering Research Council of Canada, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Impaired amyloid beta (Aβ) clearance contributes to sporadic Alzheimer's disease (AD). This study investigated retinal Aβ clearance involving neuronal, glial, and vascular interactions at the inner blood–retina barrier (iBRB), a functional analog of the blood–brain barrier (BBB). METHODS Retinal wholemounts from AD donors and controls were analyzed alongside transgenic amyloid precursor protein/presenilin 1 (APP‐PS1) and non‐carrier control mouse retinal cross‐sections using three‐ and two‐dimensional ex vivo imaging. RESULTS AD neuroretinas displayed increased larger Aβ42 deposits, microglial elongation, and substantial reductions in macroglial support and water channel expression. The uptake of soluble Aβ oligomers (SAβOs) by peripheral macrophage‐like, Aβ‐binding myeloid lineage cells was also diminished. In APP‐PS1 mice, elevated glia levels, alongside increased APP/Aβ expression, suggest gliosis and failures in clearance processes with disease progression. DISCUSSION Ex vivo three‐dimensional retinal imaging at the iBRB provides novel insights into Aβ clearance in AD, which is difficult to replicate in ex vivo brain studies at the BBB. Highlights Impaired clearance mechanisms play a key role in sporadic AD. The iBRB serves as a functional analog to the BBB. At the iBRB, the glymphatic system and microglial phagocytosis help mitigate Aβ burden. Peripheral macrophage‐like myeloid lineage cells may aid SAβO clearance. The imaging plane (surface vs cross‐section) may affect AD pathogenesis findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesBlood-Retinal BarrierRetinaAnimalsMice, TransgenicHumansMiceImaging, Three-DimensionalAmyloid beta-Protein PrecursorPresenilin-1Disease Models, AnimalMaleFemaleBlood-Brain BarrierMicrogliaAged

Stichwörter der Autor:innen

Alzheimer's retinaglymphatic structuresinner blood–retina barriermicrogliasoluble Aβ oligomer

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorPresenilin-1

Autor:innen und Institutionen

  • Department of Ophthalmology & Visual Sciences, Faculty of Medicine, The University of British Columbia, Eye Care Centre, Vancouver, BC, Canada.
  • Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pathology and Laboratory Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
  • Division of Neurology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
  • Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.

Förderung

  • Alzheimer Society of Canada and Brain Canada
  • National Sciences and Engineering Research Council of Canada
  • NIA NIH HHS
  • Canadian Institute of Health Research
  • NCATS/NIH
  • Vanderbilt CTSA Grant
  • NIH HHS
  • Vanderbilt-Ingram Cancer Center Shared Resource Scholarship

Zitieren

APA

Wijesinghe, P., Hosseini, A., Campbell, M., Tejpal, S., Haynes, J., Xi, J., Mackenzie, I. R., Hirsch-Reinshagen, V., Hsiung, G. R., Spiller, B. W., Wadzinski, B. E., Pham, W., & Matsubara, J. A. (2025). Decoding amyloid beta clearance systems at inner blood–retina barrier using three‐dimensional ex vivo retinal imaging in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70592

Vancouver

Wijesinghe P, Hosseini A, Campbell M, Tejpal S, Haynes J, Xi J, et al. Decoding amyloid beta clearance systems at inner blood–retina barrier using three‐dimensional ex vivo retinal imaging in Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70592

BibTeX
@article{Wijesinghe2025,
  author = {Wijesinghe, Printha and Hosseini, Amir and Campbell, Matthew and Tejpal, Shivani and Haynes, Justin and Xi, Jeanne and Mackenzie, Ian R and Hirsch-Reinshagen, Veronica and Hsiung, Ging-Yuek Robin and Spiller, Benjamin W and Wadzinski, Brian E and Pham, Wellington and Matsubara, Joanne A},
  title = {Decoding amyloid beta clearance systems at inner blood–retina barrier using three‐dimensional ex vivo retinal imaging in Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70592}
}
Kostenlos starten →